TOKYO and BOSTON, July 21, 2020 /PRNewswire/ -- and July 22, 2020 - Chugai Pharmaceutical Co., Ltd. (TOKYO: 4519) and Biofourmis, a Boston-based digital therapeutics company, announced that they have ...
Correspondence to Dr Eamonn Delahunt, School of Public Health, Physiotherapy & Sports Science, University College Dublin, Dublin 4, Ireland; eamonn.delahunt{at}ucd.ie Within a year of first-time acute ...
Japanese pharmaceutical giant Chugai and Boston-based digital therapeutics company Biofourmis announced that they have partnered to develop a digital solution for the objective assessment of pain ...
Setting assessment objectives is the first and most crucial step in any assessment process. It defines the purpose, scope, and expected outcomes of the assessment, and ensures that every further step ...
Identifying and validating disease-causing genes that are viable as drug targets is a key challenge in drug discovery. Large-scale multi-omics initiatives are deepening our understanding of cancer and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results